ATLANTA, Ga., June 17, 2025 /PRNewswire/ -- Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the clinical ...
According to Future Market Insights (FMI), the global home sleep apnea testing market is projected to grow from USD 734.4 ...
"Cellular-enabled SANSA paves the way for sleep physicians and technicians to receive data in near real-time once a test is complete, enabling more efficient workflows and accelerating time to care.
SANSA revealed sleep apnea during a daytime nap as well as overnight sleep, highlighting how typical overnight-only home sleep apnea testing may miss the full burden of disease and not capture ...
Central sleep apnea validation: Promising SANSA diagnostic performance – Researchers developed and tested a new algorithm to detect central sleep apnea (CSA) using SANSA and compared results to in-lab ...
ATLANTA, Aug. 7, 2024 /PRNewswire/ -- Huxley Medical, a developer of technologies that streamline cardiopulmonary care, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) ...
According to Future Market Insights (FMI), the global home sleep apnea testing market is projected to grow from USD 734.4 million in 2026 to USD 996.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results